Cost analysis of migraine pharmacotherapy with selective 5HT1 receptor agonists in Ukraine
The cost analysis for the relief of migraine attack using selective 5HT1-receptor agonists (frovatriptan, zolmitriptan, risatriptan, sumatriptan) of domestic and imported manufacturers in various dosages and forms of production in the proposed resource online pharmacy chains of Lviv for their effici...
Main Authors: | Yaryna Hrynkiv, Olha Zaliska, Nataliia Maksymovych, Oksana Blavatska |
---|---|
Format: | Article |
Language: | English |
Published: |
Pensoft Publishers
2021-02-01
|
Series: | Pharmacia |
Online Access: | https://pharmacia.pensoft.net/article/51740/download/pdf/ |
Similar Items
-
Cost analysis of epilepsy pharmacotherapy by valproic acid and carbamazepine
by: Ia. O. Grynkiv, et al.
Published: (2018-08-01) -
Analysis of development dynamics of the program «Affordable medicines» in Ukraine and Lviv region
by: O. B. Blavatska, et al.
Published: (2020-05-01) -
5-HT1 receptor inhibitors (triptans) for the treatment of migraine during pregnancy: an analysis of the instructions for medical use
by: Y. O. Hrynkiv
Published: (2022-10-01) -
Analysis of the vitamin’s list with pharmacoeconomic rates for the treatment of long covid conditions during the pandemic COVID-19 in Ukraine
by: Ya. O. Hrynkiv, et al.
Published: (2021-10-01) -
CGRP Receptor Antagonists and 5-HT1F Receptor Agonist in the Treatment of Migraine
by: Matilde Capi, et al.
Published: (2021-04-01)